PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2017 | 7 | 1 | 38-43
Article title

Invasive fungal infection in a child with Ewing’s sarcoma

Content
Title variants
Languages of publication
EN
Abstracts
EN
Invasive fungal infection (IFI) in patients with malignant solid tumours is rare, but it highly increases the risk of cancer recurrence because of prolonged discontinuation of cancer treatment. This paper presents a case of IFI induced by Candida glabrata in a 14-year-old girl with advanced Ewing’s sarcoma and metastases to the bone marrow. She was intensively treated with chemotherapy (CWS, CEVAIE, EWING 2008 + VIDE) and radiotherapy. As the treatment was ineffective, the tumour was surgically removed from the sacrum, and VAI chemotherapy was administered. Due to the symptoms of infection, antifungal treatment was initiated with caspofungin, followed by prophylaxis with posaconazole. In terms of anti-cancer treatment, the patient received megatherapy with auto-HSCT. Signs of infection and gastrotoxic complications developed, which is why broad-spectrum antibiotics and amphotericin B lipid complex were administered. Even so, a multisystem IFI appeared, causing the patient’s death. In multidrug chemotherapy with extended periods of agranulocytosis, primary prevention should be considered, similar to the one offered to patients with haematological malignancies.
Discipline
Publisher

Journal
Year
Volume
7
Issue
1
Pages
38-43
Physical description
Contributors
  • Department and Clinic of Paediatrics, Haematology and Oncology, Medical University of Gdansk, Poland, edrozynska@gumed.edu.pl
author
  • Department and Clinic of Paediatrics, Haematology and Oncology, Medical University of Gdansk, Poland
  • Department and Clinic of Paediatrics, Haematology and Oncology, Medical University of Gdansk, Poland
References
  • 1. Dzierżanowska D, Gil L, Jakubas B et al. Epidemiologia i diagnostyka mikrobiologiczna inwazyjnej choroby grzybiczej. Post Nauk Med 2015; 6: 403-409.
  • 2. Kałwak K. Profilaktyka zakażeń grzybiczych u dzieci poddawanych transplantacjom komórek hematopoetycznych. Acta Hematol Pol 2014; 45(4): 354-359.
  • 3. Stefaniak MJ. Postępowanie u chorych ze schorzeniami onkohematologicznymi wymagających terapeutycznego zastosowania leków przeciwgrzybiczych. In: Kowalczyk J.R. (ed). Onkohematologia dziecięca – co nowego? Cornetis, Wrocław 2009: 84-116.
  • 4. Choi YB, Yi ES, Kang JM et al. Infectious Complications during Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Children with High-Risk or Recurrent Solid Tumors. PLoS ONE 2016; 11(9): e0162178. DOI: 10.1371/journal.pone.0162178.
  • 5. Styczyński J.: Leczenie zakażeń u dzieci ze schorzeniami onkohematologicznymi. Post Nauk Med 2014; 4: 292-297.
  • 6. Science M, Robinson PD, MacDonald T et al. Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients. Pediatr Blood Cancer 2014; 61(3): 393-400.
  • 7. Stieglitz E, Hsiang MS, Simko JP et al. Pulmonary coccidiomycosis masquerading as refractory metastatic Ewing sarcoma. J Pediatr Hematol Oncol 2014; 36(1): 57-60.
  • 8. Prażyńska M, Gospodarek-Komkowska E. Leczenie wybranych postaci kandydozy zgodnie z aktualnymi wytycznymi Amerykańskiego Towarzystwa Chorób Zakaźnych (IDSA 2016). Zakażenia 2016; 16(4): 41-52.
  • 9. Devrim I, Yaman Y, Demirağ B et al. A single center’s experience with Candida parapsilosis related long-term central venous access device infections: the port removal decision and its outcomes. Pediatr Hematol Oncol 2014; 31(5): 435-441.
  • 10. Cornely OA, Gachot B, Akan H et al. Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Infectious Diseases Group. Clin Infect Dis 2015; 61(3): 324-331.
  • 11. Rutkowski P, Mazurkiewicz T, Fijuth J et al. Mięsaki kości. In: Rutkowski P, Mazurkiewicz T (ed). Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych – 2013. Volume 2. Via Medica, Gdańsk 2013: 440-456.
  • 12. Warady BA, Bashir M, Donaldson A. Fungal peritonitis in children receiving peritoneal dialysis: A report of NAPRTCS. Kidney Int 2000; 58: 384-389.
  • 13. Biliński P, Seferyńska I, Warzocha K. Diagnostyka i leczenie układowych zakażeń grzybiczych w onkohematologii. Onkol Prakt Klin 2008; 4(1): 15-24.
  • 14. Glockner A, Cornely OA. Candida glabrata – unique features and challenges in the clinical management of invasive infections. Mycoses 2015; 58(8): 445-450.
  • 15. Tibúrcio FR, de Sá Rodrigues KE, Vasconcelos HM et al. Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report. BMC Pediatr 2015; 3(15): 108-112.
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-b41e9c8b-9f34-4e43-be85-380eb75a170b
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.